Atea Study Site

Bucharest 21105

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Chronic Hepatitis C Virus, HCV, Hepatic Cirrhosis, Hepatitis C, Hepatitis C, Chronic, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)

Studies at this site

• A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV — Completed
• SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 — Completed
• Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting — Stopped early